Zenas BioPharma

IPO

Enabling patients with autoimmune diseases to reimagine life.

Public · Boston, United States · Founded 2022 · $318.0M raised

Employees
51–200
Founded
2022
Business Model
B2B
Total Funding
$318.0M
Last Round
$200.0M Series CMay 2024
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Zenas BioPharma is a clinical-stage global biopharmaceutical company focused on developing and commercializing transformative immunology-based therapies for autoimmune diseases with significant unmet patient needs. The company's proven leadership team advances a pipeline targeting conditions where current treatments remain inadequate. Zenas operates with a global development model, combining scientific rigor with commercial strategy.

Summary

Zenas BioPharma is a Biotech company based in Boston, United States, founded in 2022. It has raised $318.0M in total across 2 rounds, most recently a $200.0M Series C round in May 2024. Investors include SR One, Khosla Ventures and New Enterprise Associates.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOSep 2024
$225.0M

Sign up to see all 3 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zenas BioPharma on Indexed.vc
<a href="https://indexed.vc/companies/zenas-biopharma"><img src="https://indexed.vc/api/badge/company/zenas-biopharma" alt="Zenas BioPharma on Indexed.vc" width="260" height="76" /></a>